Aytu Biopharma Inc
AYTU2.650USD
+0.250+10.42%
Cierre 08/04, 16:00（ET）Cotizaciones retrasadas 15 min
16.35MCap. mercado
9.98P/E TTM
Más Datos de Aytu Biopharma Inc Compañía
Aytu BioPharma, Inc. is a pharmaceutical company focused on commercializing novel therapeutics. The Company's business is focused on its prescription pharmaceutical products sold primarily through third party wholesalers and pharmacies and which primarily consists of two product portfolios. The first consists of two products for the treatment of ADHD: Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) and Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets. The second consists primarily of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine suspension containing carbinoxamine indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various formulations for infants and children with fluoride deficiency.
Información de la empresa
Símbolo de cotizaciónAYTU
Nombre de la empresaAytu Biopharma Inc
Fecha de salida a bolsaOct 20, 2017
Director ejecutivoMr. Joshua R. (Josh) Disbrow
Número de empleados99
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 20
Dirección7900 E. Union Avenue
CiudadDENVER
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal80237
Teléfono17204376580
Sitio Webhttps://aytubio.com/
Símbolo de cotizaciónAYTU
Fecha de salida a bolsaOct 20, 2017
Director ejecutivoMr. Joshua R. (Josh) Disbrow
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
29.46K
+130.24%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
23.81K
+1.79%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
16.00K
--
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
11.15K
--
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
9.82K
--
Mr. Abhinav (Abi) Jian
Mr. Abhinav (Abi) Jian
Independent Director
Independent Director
--
--
Mr. John A. Donofrio, Jr.
Mr. John A. Donofrio, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
29.46K
+130.24%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
23.81K
+1.79%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
16.00K
--
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
11.15K
--
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
9.82K
--
Mr. Abhinav (Abi) Jian
Mr. Abhinav (Abi) Jian
Independent Director
Independent Director
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
ADHD portfolio
15.39M
83.40%
Pediatric portfolio
3.06M
16.58%
Other
4.00K
0.02%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
18.45M
100.00%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
ADHD portfolio
15.39M
83.40%
Pediatric portfolio
3.06M
16.58%
Other
4.00K
0.02%
Estadísticas de accionistas
Actualizado: sáb., 28 de jun
Actualizado: sáb., 28 de jun
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Nantahala Capital Management, LLC
12.11%
Kanen Wealth Management, LLC
6.39%
Lytton (Laurence W)
5.64%
Stonepine Capital Management, LLC
5.17%
Disbrow (Joshua R.)
1.71%
Other
68.99%
Accionistas
Accionistas
Proporción
Nantahala Capital Management, LLC
12.11%
Kanen Wealth Management, LLC
6.39%
Lytton (Laurence W)
5.64%
Stonepine Capital Management, LLC
5.17%
Disbrow (Joshua R.)
1.71%
Other
68.99%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
14.00%
Investment Advisor/Hedge Fund
12.67%
Individual Investor
8.50%
Investment Advisor
0.65%
Other
64.18%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
67
3.22M
35.83%
+940.81K
2025Q1
66
2.05M
28.89%
-146.84K
2024Q4
71
2.05M
33.28%
-280.21K
2024Q3
75
2.20M
40.58%
-328.29K
2024Q2
78
2.26M
43.50%
-3.54K
2024Q1
82
1.99M
41.33%
-356.06K
2023Q4
85
1.96M
40.81%
-395.45K
2023Q3
91
1.92M
40.24%
-406.76K
2023Q2
100
1.89M
40.00%
+821.00K
2023Q1
134
705.12K
28.77%
-175.85K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Nantahala Capital Management, LLC
1.09M
12.11%
--
--
Jun 06, 2025
Kanen Wealth Management, LLC
573.36K
6.39%
+407.09K
+244.84%
Jun 26, 2025
Lytton (Laurence W)
506.61K
5.64%
+506.61K
--
Jun 09, 2025
Stonepine Capital Management, LLC
463.72K
5.17%
+56.17K
+13.78%
Mar 31, 2025
Disbrow (Joshua R.)
153.26K
1.71%
+66.67K
+76.99%
Jun 09, 2025
Renaissance Technologies LLC
76.82K
0.86%
+1.40K
+1.86%
Mar 31, 2025
Armistice Capital LLC
57.60K
0.64%
-92.40K
-61.60%
Mar 31, 2025
Geode Capital Management, L.L.C.
53.94K
0.6%
+11.21K
+26.23%
Mar 31, 2025
Citadel Advisors LLC
30.49K
0.34%
+19.43K
+175.66%
Mar 31, 2025
Disbrow (Jarrett T)
29.46K
0.33%
+16.67K
+130.24%
Jun 09, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares Core S&P Total U.S. Stock Market ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proporción0%
DFA Dimensional US Sustainability Core 1 ETF
Proporción0%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Jan 05, 2023
Merger
20<1
Jan 05, 2023
Merger
20<1
Jan 05, 2023
Merger
20<1
Jan 05, 2023
Merger
20<1
Dec 08, 2020
Merger
10<1
Dec 08, 2020
Merger
10<1
Fecha
Tipo
Relación
Jan 05, 2023
Merger
20<1
Jan 05, 2023
Merger
20<1
Jan 05, 2023
Merger
20<1
Jan 05, 2023
Merger
20<1
Dec 08, 2020
Merger
10<1
Dec 08, 2020
Merger
10<1
Dec 08, 2020
Merger
10<1
Dec 08, 2020
Merger
10<1
